Meso Aftermath Archived

Biotech resurgence: M&A activity and market performance

Activity declining — narrative losing relevance.

Score
0.3
Velocity
▲ 0.0
Articles
13
Sources
2

Top Movers

TickerSectorChange
VRA
Consumer Discretionary+17.4%
VRTX
Healthcare+16.3%

Sentiment Timeline

Sector Performance

Stock Performance

Event Timeline

Mar 31, 2026
MRNA, SRPT, and KRYS Phase 3 Data Will Shape XBI’s 2026 Performance Neutral
Mar 26, 2026
2 Healthcare Stocks That Could Soar Over the Next 5 Years Bullish
Mar 25, 2026
Moderna Stock is Soaring. Is It Too Late to Buy? Bullish
Mar 22, 2026
Two Biotech Stocks Hover Near Highs; Natural Gas And Finance Names Show … Bullish
Mar 21, 2026
This Biotech Was Quietly Bought Before a $58 Per Share Takeout Bullish
Mar 20, 2026
This $91 Million Position Signals Conviction in a Biotech Stock Eyeing FDA … Bullish

Related Articles

This Biotech Was Quietly Bought Before a $58 Per Share Takeout

Yahoo Finance · Mar 21, 2026
Mixed

This $91 Million Position Signals Conviction in a Biotech Stock Eyeing FDA Decision This Year

Nasdaq · Mar 20, 2026
Mixed

My Top 3 Drug Stocks for March 2026

Nasdaq · Mar 20, 2026
Bearish

Why biotech is back: IBT portfolio manager’s view

Yahoo Finance · Mar 20, 2026
Mixed

Timeline

First SeenMar 20, 2026
Last UpdatedMar 20, 2026